April 2nd 2024, 3:00pm
Melanoma survivors may have an increased risk of recurrence, which may heighten fear and worry, but “it’s OK and normal to be worried,” a doctor said.
March 29th 2024, 3:00pm
From Fortnight player, “Ninja” announcing his melanoma diagnosis to an LSU quarterback sporting the name of his teammate with brain cancer, here’s what’s going on in the oncology space this week.
March 15th 2024, 3:00pm
From Oliva Munn and Christine Brinkley discussing their cancer to Donnie Iris returning to the stage after his experience with the disease, here is what’s happening in the oncology space this week.
February 22nd 2024, 8:00pm
Treatment with Amtagvi, a TIL therapy recently approved for advanced melanoma, includes a three-week hospital stay upfront, but may lead to years of monitoring without more treatment needed, an expert explained.
February 20th 2024, 8:00pm
Personalized cancer vaccines are on the horizon and could be available for some patient populations as soon as next year, one expert said.
February 15th 2024, 8:00pm
Moderna and Merck have initiated V940-001, a phase 3 study evaluating vaccine mRNA-4157 and anti-PD-1 therapy Keytruda as postsurgical treatment for stage 2B to 4 melanoma.
January 26th 2024, 4:14pm
From the Duchess of York receiving a skin cancer diagnosis to Selena Gomez contacting a fan with stage 4 disease, here’s what is happening in the oncology space this week.
January 7th 2024, 3:00pm
Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.
December 22nd 2023, 4:00pm
As ‘Big Bang Theory’ star Kate Micucci announced that she is cancer-free and ‘Married at First Sight’ dating coach Mel Schilling announced her cancer diagnosis, here is what’s happening in the oncology space this week.
December 15th 2023, 10:00pm
Patients with advanced-stage melanoma continue to experience reduced risk of recurrence or death following treatment with a combination of mRNA vaccine mRNA-4157 (V940) and Keytruda, an anti-PD-1 therapy, according to recent study findings.
An Expert Breaks Down Lymphedema Following Cancer Care
Melanoma Taught Me Faith, Gratitude and That Nothing Is Permanent
FDA Approves Avastin Biosimilar Jobevne Across Several Cancer Types
Managing Cancer Demands Flexibility and a Strategic Mindset